Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility.
The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.
Company Details
- Employees
- 5
- Founded
- 2013
- Address
- 1361 Amsterdam Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://Www.hemogenyx.com
- Keywords
- Athenex.
- HQ
- New York, NY
Hemogenyx Pharmaceuticals Questions
Hemogenyx Pharmaceuticals's website is http://Www.hemogenyx.com
Hemogenyx Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/hemogenyx-pharmaceuticals
Hemogenyx Pharmaceuticals has
5 employees.
View email and phone details for 5
employees at Hemogenyx Pharmaceuticals.
Hemogenyx Pharmaceuticals's industry is
Biotechnology Research
Hemogenyx Pharmaceuticals's top competitors are
Estrella Biopharma, Inc,
Pine Pharmaceuticals,
Bellicum Pharmaceuticals, Inc.,
Veongen Therapeutics Gmbh,
Xellsmart Bio,
Hemogenix, Inc,
Cardurion Pharmaceuticals,
Athenex,
Oric Pharmaceuticals Inc.,
Hemogenyx Pharmaceuticals Ltd..
Hemogenyx Pharmaceuticals's categories are Biotechnology Research
Hemogenyx Pharmaceuticals's founding year is 2013
